Fatal Pneumocystis pneumonia following rituximab administration for rheumatoid arthritis.
Teichmann
L L
LL
Woenckhaus
M
M
Vogel
C
C
Salzberger
B
B
Schölmerich
J
J
Fleck
M
M
D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D058846:Antibodies, Monoclonal, Murine-Derived; D018501:Antirheumatic Agents / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D017809:Fatal Outcome; D006801:Humans; D008297:Male; D008875:Middle Aged; D009894:Opportunistic Infections / Q000139:chemically induced*; D011020:Pneumonia, Pneumocystis / Q000139:chemically induced*; D000069283:Rituximab
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D018501:Antirheumatic Agents; D000069283:Rituximab